Damage to articular cartilage in horses is a common cause of pain, lameness, and decreased athletic performance. It can result from injury, training overload, congenital defects, or as part of osteoarthritis. Since cartilage has no blood supply, its natural ability to regenerate is limited, which means that conventional treatment methods are not sufficient.
The traditional approach includes NSAIDs, cartilage-supporting supplements, intra-articular injections (hyaluronic acid, steroids), and physical therapy. These methods alleviate symptoms but do not lead to cartilage regeneration.
MSCs demonstrate the ability to differentiate into chondrocytes and secrete factors that support cartilage regeneration. This is currently the most effective method of repairing cartilage defects in horses. They are used in moderate to severe cases of damage.
👉 Check out how mesenchymal stem cells work
PRP provides growth factors that improve the joint environment and stimulate repair processes. It can be used in early cartilage damage and as support in recovery after injuries.
In cases of chronic joint inflammation, the use of IL-1 helps reduce inflammation and relieve pain by supporting the action of MSCs and PRP.
👉 Learn more about IL-1 therapy and pain treatment
Damage to articular cartilage in horses is a serious orthopedic problem that limits the animal's performance and sporting career. Standard methods treat the symptoms, while modern biological therapies—PRP, MSC, and IL-1—support actual cartilage regeneration and enable a return to activity.
No – its ability to regenerate is minimal, which is why biological therapies are needed.
In initial damage, yes, but in moderate and severe cases, MSCs are necessary.
Long-term improvement in joint function, reduction in pain and partial restoration of cartilage.
Yes, especially in advanced cases, to reduce inflammation and improve the horse's comfort.